FRANCISCO
VANACLOCHA SEBASTIÁN
Investigador en el periodo 2009-2016
University of California Los Angeles
Los Ángeles, Estados UnidosPublicaciones en colaboración con investigadores/as de University of California Los Angeles (1)
2017
-
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study
Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 10, pp. 1693-1699